Lisata Therapeutics, Inc. (LSTA)
1.05
+0.01
(+0.96%)
USD |
NASDAQ |
Oct 21, 16:00
1.05
0.00 (0.00%)
After-Hours: 17:53
Lisata Therapeutics Price : 1.05 for Oct. 21, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 1.00 | 1.08 | 0.996 | 1.04 | 113743.0 |
| Oct 19, 2026 | 1.03 | 1.04 | 0.9604 | 1.00 | 96293.00 |
| Oct 16, 2026 | 1.04 | 1.07 | 1.02 | 1.03 | 57127.00 |
| Oct 15, 2026 | 1.05 | 1.07 | 1.00 | 1.07 | 23166.00 |
| Oct 14, 2026 | 1.00 | 1.07 | 0.996 | 1.02 | 80257.00 |
| Oct 13, 2026 | 1.10 | 1.150 | 0.99 | 1.08 | 146856.0 |
| Oct 12, 2026 | 1.04 | 1.06 | 0.98 | 1.05 | 166669.0 |
| Oct 09, 2026 | 1.28 | 1.28 | 1.02 | 1.06 | 280231.0 |
| Oct 08, 2026 | 1.22 | 1.31 | 1.13 | 1.20 | 704822.0 |
| Oct 07, 2026 | 1.22 | 1.22 | 1.16 | 1.17 | 13583.00 |
| Oct 06, 2026 | 1.31 | 1.320 | 1.14 | 1.21 | 124182.0 |
| Oct 05, 2026 | 1.45 | 1.475 | 1.26 | 1.26 | 90754.00 |
| Oct 02, 2026 | 1.49 | 1.50 | 1.47 | 1.47 | 3681.00 |
| Oct 01, 2026 | 1.42 | 1.56 | 1.42 | 1.49 | 63139.00 |
| Sep 30, 2026 | 1.47 | 1.50 | 1.435 | 1.44 | 17080.00 |
| Sep 29, 2026 | 1.48 | 1.536 | 1.44 | 1.47 | 50722.00 |
| Sep 28, 2026 | 1.56 | 1.57 | 1.50 | 1.50 | 38184.00 |
| Sep 25, 2026 | 1.54 | 1.58 | 1.49 | 1.58 | 47898.00 |
| Sep 24, 2026 | 1.47 | 1.53 | 1.435 | 1.50 | 25475.00 |
| Sep 23, 2026 | 1.46 | 1.50 | 1.40 | 1.435 | 77242.00 |
| Sep 22, 2026 | 1.55 | 1.60 | 1.44 | 1.48 | 152756.0 |
| Sep 21, 2026 | 1.64 | 1.65 | 1.54 | 1.56 | 228887.0 |
| Sep 18, 2026 | 1.71 | 1.76 | 1.61 | 1.70 | 293909.0 |
| Sep 17, 2026 | 2.50 | 2.56 | 1.50 | 1.74 | 3.044M |
| Sep 16, 2026 | 1.53 | 1.57 | 1.47 | 1.47 | 93541.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.20 |
| Alnylam Pharmaceuticals, Inc. | 225.04 |
| Anika Therapeutics, Inc. | 20.56 |
| Savara, Inc. | 4.665 |
| Vericel Corp. | 40.99 |
Price Related Metrics
| PS Ratio | 93.67 |
| Price to Book Value | 1.161 |
| Earnings Yield | -156.3% |
| Market Cap | 9.575M |